Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008–2018
In US postmenopausal women, HRT is associated with a reduced risk of pancreatic cancer, especially those aged 55-74 year. Further study is needed to clarify the mechanisms underlying the associations.
Authors
- Ruirui Ma (ORCID: https://orcid.org/0000-0001-5968-2040)
- Dekai Guo
- Haibing Gong
- Congjun Wang (ORCID: https://orcid.org/0000-0001-9554-9394)
- Xinyu Wang (ORCID: https://orcid.org/0000-0002-0062-1208)
- Lei Liu
Institutions
- Renji Hospital (CN)
- University of California San Diego (US)
- Songjiang District Central Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37588
- Citations
- 2
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China